Norvir (Ritonavir)

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Norvir (Ritonavir)

The Basics | News | Research

See also: Medication Side Effects | Drug Interactions

Brand Name:	Norvir
Generic Name:	Ritonavir, RTV
Adult Single Dose:	Six 100-mg capsules (twice a day); start with three capsules twice a day and increase to full dose over 14 days
Food & Liquid Restrictions:	Take with food
Drug Class:	PI

The Basics

An Overview of Norvir (Ritonavir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Ritonavir (Norvir) (August 23, 2008)
To read PDF, click here
From AIDS InfoNet
Norvir (Ritonavir, RTV) (January/February 2008)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Norvir (Ritonavir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Patient Information About Norvir (Ritonavir) (PDF) (May 2007)
From Abbott Laboratories
Ritonavir (Norvir) Simple Fact Sheet (August 15, 2006)
From AIDS Treatment Data Network
Norvir (Ritonavir) (November 2005)
To read PDF, click here
From The Center for AIDS
My Friend Ritonavir: The Concept of "Boosting" (December 2004)
This research update reviews what we know about boosting HAART regimens with ritonavir (free registration required).
In The PRN Notebook
Drug Interactions: Ritonavir (August 2004)
From Project Inform
Protease Inhibitor Therapy: Boosted and Double-Boosted Options to the Fore (March 2004)
In The PRN Notebook
Abbott Virology Patient Assistance Program Application (PDF) (January 2004)
If you are having problems paying for ritonavir (Norvir), fill out Abbott's form and perhaps you'll be able to get this medication at no cost.
From Abbott Laboratories
Drug Interactions: Ritonavir as PI Booster (July 2001)
From Project Inform

News

Ritonavir Price Increase Responses (Regularly Updated)
To help its members remain informed, the Academy has compiled the following list of letters from various organizations and groups of providers responding to the price increase.
From American Academy of HIV Medicine
Updated Labeling for Norvir (Ritonavir) Soft Capsule and Oral Solution (September 2, 2008)
From U.S. Food and Drug Administration
Newly-Unsealed Documents Shed Light on Abbott Labs' 400% Norvir Price Hike (May 12, 2008)
Union, consumer groups decry Abbott for putting profits before HIV/AIDS patients' needs
In A Closer Walk: A Film by Robert Bilheimer, from Community Catalyst
Glaxo Joins Lawsuit Against Abbott Over Price of Norvir (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Pharmacies, Drug Wholesaler File Lawsuit Against Abbott Over Norvir Price (October 30, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
New Dosing Regimen for Lexiva Approved (October 12, 2007)
From U.S. Food and Drug Administration
Interaction Warning: Ritonavir and Blood-Pressure Drug Nifedipine (December 12, 2006)
From aidsmap.com
FDA Approves Pediatric Dosing for Ritonavir (October 6, 2005)
From U.S. Food and Drug Administration
Norvir (Ritonavir) 100 mg Now Available in 30-Count Bottle (May 13, 2005)
From U.S. Food and Drug Administration
AIDS Treatment Activists Coalition: AIDS Activists Outraged by Abbott Settlement With AIDS Healthcare Foundation (July 16, 2004)
To read PDF, click here
From AIDS Treatment Activists Coalition
Food and Drug Administration Warning Letter to Abbott Laboratories (PDF) (June 10, 2004)
The FDA warns Abbott Laboratories that some of its marketing of its AIDS drug ritonavir (Norvir) in certain patient information materials is false and misleading.
From U.S. Food and Drug Administration
Ritonavir Sales Projected to Top $2B in Next Decade; Insurers' Costs Skyrocket (June 7, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Aetna Files Lawsuit Against Abbott Over 400% Price Increase of Ritonavir (May 27, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
U.S. Government Holds Hearing on Generic Production of Ritonavir (May 26, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Abbott's Norvir Price Hike Is Bad Medicine (May/June 2004)
Bob Huff explains why the December 2003 ritonavir price increase may well doom the development of boosted protease inhibitors.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Cruising With Lazarus: Abbott Laboratories' Pricing Malfunction (May/June 2004)
In Survival News, from AIDS Survival Project
Research and Development Costs, Unplugged (May 2004)
A chart comparing the R&D costs of five antiretrovirals.
In TAGline, from Treatment Action Group
AIDS Advocates, Religious Groups Protest Norvir Price Increase at Abbott Shareholders' Meeting (April 27, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Two HIV-Infected Patients File U.S. Antitrust Suit Against Ritonavir Price Hike (April 20, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Hearing on Drug Reimportation to Include Discussion of Abbott's Pricing of Antiretroviral Norvir (April 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
AIDS Healthcare Foundation Files Suit Against Abbott Alleging False Advertising After 400% Price Increase on AIDS Drug (March 19, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Test Positive Aware Network Responds to Abbott Regarding Norvir Price Increase (February 13, 2004)
From Test Positive Aware Network
Abbott Offers Concessions in Response to Wide Protest of Ritonavir Price Hike (PDF) (February 4, 2004)
From Abbott Laboratories
AAHIVM Urges Abbott to Reconsider Ritonavir Price Increase (January 2, 2004)
From American Academy of HIV Medicine
HIVMA Asks Abbott to Reconsider Price Hike (December 18, 2003)
From HIV Medicine Association
Rescue Regimens: The Value of Protease-Inhibitor Boosting (September 2001)
In Body Positive, from Body Positive
Is Once Daily Indinavir With Ritonavir On the Way? (December 20, 2000)
From Canadian AIDS Treatment Information Exchange
Norvir: Liver Damage Reports Merit Closer Examination (February 2000)
In Positive Living, from AIDS Project Los Angeles
A Spoon Full of Sugar (Winter 1999)
In STEP Perspective, from Seattle Treatment Education Project
Ritonavir and Menstruation (September 1999)
In Project Inform Perspective, from Project Inform
Ritonavir Capsules Available (September 1999)
In Project Inform Perspective, from Project Inform
Ritonavir (Norvir®) Capsules Back: Refrigeration Optional (July 2, 1999)
From AIDS Treatment News
The Norvir Soft-Gel Cap Is Back: Getting the Bad Taste Out of Your Mouth (Summer 1999)
In STEP Perspective, from Seattle Treatment Education Project
A Long Wait for Ritonavir Capsules (October 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
An In-Depth Look at the Problems With Norvir (September 1, 1998)
From International Association of Physicians in AIDS Care
Warning! Norvir (Ritonavir) Problems With Capsule Manufacturing (September 1998)
In Notes From the Underground, from PWA Health Group
IAPAC Norvir Advisory Launched in Response to Norvir Capsule Manufacturing Problem (August 26, 1998)
From International Association of Physicians in AIDS Care
Suggestions for Taking the Liquid Formulation of Ritonavir (August 21, 1998)
From AIDSinfo
Ritonavir Capsule Manufacturing Problems Will Require Switch to Liquid Formulation (August 7, 1998)
From AIDS Treatment News
Ritonavir Users Put on Liquid Diet (July/August 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Ritonavir: New Approval for Children (March 21, 1997)
From AIDS Treatment News
FDA Approves Nelfinavir, Ritonavir Approved for Children, More Pharmacies to Carry Crixivan (March 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Warning: Ritonavir and Ecstasy (March 1997)
From PWA Health Group
Medications Contraindicated With the Use of Ritonavir (April 3, 1996)
In TAGline, from Treatment Action Group
Ritonavir Financial Assistance (March 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.